Apria warned by FDA over oxygen supplies:
This article was originally published in Clinica
The FDA has warned US medical oxygen company Apria Healthcare that one of its filling facilities does not meet government standards. The filling plant in Tampa, Florida, was accused of having "no documentation or inconsistent evidence of the oxygen's identity, strength, quality and purity". The $1.1 billion company has 300 branches in the US and has been warned on previous occasions. The company says that patient safety had not been threatened.
You may also be interested in...
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.